Liability for Adverse Events in Direct-to-Consumer Advertising [4] (multiple letters)

JAMA

Volumn 289, Issue 20, 2003, Pages 2646-2647

  Shein, David ^a   Evans, George W ^b   Friede, Arnold I ^b   Mello, Michelle M ^c   Rosenthal, Meredith B ^c   Neumann, Peter J ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b PFIZER INC   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; DRUG MISUSE; HUMAN; LEGAL LIABILITY; LETTER; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RESPONSIBILITY; RISK BENEFIT ANALYSIS; ADVERTIZING; DOCTOR PATIENT RELATION; LEGAL ASPECT; NOTE; PATIENT PARTICIPATION; RISK; UNITED STATES;

ADVERTISING; DRUG INDUSTRY; LIABILITY, LEGAL; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTIONS, DRUG; RISK; UNITED STATES;

EID: 0346014784     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.20.2646-a     Document Type: Letter

References (0)